5 results about "Hearing disorder" patented technology

The invention of a device and system for reduction of tinnitus defects and hearing disorders in the ear and to correct the defects along with real-time feedback with the help of brain output signal recording technology to determine the amount of corrections is related to a device and system to control and reduce hyperacusis, tinnitus and hearing loss and a flexible wearable device that can be placed on a patient's head and also is a portable wearable device that can be connected to a mobile phone and a pair of true wireless earbuds wirelessly. This invention is a system of applying a magnetic field to the auditory cortex of the human brain to reduce hearing defects. This hat is able to simultaneously treat the patient with rTMS and monitor brain activity using fNIRS technology so that it provides accuracy in magnetic stimulation and monitoring of brain reactions.

This invention provides drugs and methods for preventing or reversing hearing loss. [Solution] A composition comprising at least two different nucleic acid vectors, each of which comprises a coding sequence encoding a different portion of the otoferrin protein, and the use of these compositions for treating hearing loss in a subject are provided herein. This disclosure is based on the discovery that a composition comprising at least two different nucleic acid vectors, each of which comprises a coding sequence encoding a different portion of the otoferrin protein, can be used to generate a sequence encoding an active otoferrin protein (e.g., full-length otoferrin protein) in mammalian cells, thereby enabling the treatment of asymptomatic sensorineural hearing loss in a subject in need.

The present disclosure provides polynucleotides containing a TMPRSS3 promoter of a region capable of specifically expressing a transgene in cochlear hair cells and sensory supporting cells. The disclosure also provides nucleic acid vectors containing these promoters operably linked to a polynucleotide encoding a polypeptide. The present disclosure provides compositions and methods for specifically inducing transgene expression in inner ear cells, such as hair cells and sensory supporting cells. The compositions described herein can be administered to a subject to treat a condition caused by inner ear cell dysfunction, such as hearing loss or vestibular dysfunction.

Acquired hearing loss due to chemotherapy or noise exposure is a major health problem, and Cisplatin chemotherapy often causes permanent hearing loss in cancer patients. However, there are no FDA-approved drugs for the treatment or prevention of Cisplatin- or noise-induced hearing loss. In one aspect, use of Niclosamide, Ingenol, and Elesclomol as an active agent to treat a hearing impairment and to prevent a hearing impairment, and methods of treating and / or preventing hearing impairments or disorders using the compositions are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Provided herein are methods and compositions for the treatment of hearing disorders by administration of a combination of two or more calcium channel blockers.